CTKB vs PG · rev $200.5M vs P/E 25, rev $84.28B
Cytek Biosciences Inc (CTKB) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
CTKB currently screens at market cap $421.8M. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the CTKB and PG stock pages for the full models.
Not investment advice.